Rapid Micro Biosystems PEG Ratio

The latest PEG ratio for RPID is -17.35. That is below the Healthcare sector average of 1.26. Investors often review this figure alongside Rapid Micro Biosystems's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, RPID currently prints -17.35 for PEG ratio, while the sector average sits near 1.26. That is roughly 1480.3% below the sector mean. Large gaps often invite a closer look at Rapid Micro Biosystems's growth, margins, and balance sheet.

A PEG ratio of -17.35 for Rapid Micro Biosystems is not 'good' or 'bad' on its own. Compare it with the peer average (1.26) and with RPID's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting RPID's PEG ratio (-17.35), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Rapid Micro Biosystems's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.